Mitchell Chan - Dec 1, 2021 Form 3 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Director
Signature
Christopher R. Sullivan, by Power of Attorney
Stock symbol
AVTX
Transactions as of
Dec 1, 2021
Transactions value $
$0
Form type
3
Date filed
12/3/2021, 07:42 PM
Next filing
Jun 15, 2022

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.